PharmaShots | Incisive News in 3 Shots

Subscribe Now

Heron Therapeutics

Heron Therapeutics Launches Aponvie for the Management of Postoperative Nausea and Vomiting in the US

Heron Therapeutics Launches Aponvie for the Management of Postoperative Nausea and Vomiting in the US

March 7, 2023

Heron Therapeutics’ Aponvie (HTX-019) Receives the US FDA’s Approval for the Prevention of Postoperative Nausea and Vomiting

Heron Therapeutics’ Aponvie (HTX-019) Receives the US FDA’s Approval for the Prevention of Postoperative Nausea and Vomiting

October 20, 2022

PharmaShots Weekly Snapshots (May 10 - 14, 2021)

PharmaShots Weekly Snapshots (May 10 - 14, 2021)

May 14, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us